Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer

H Hamakawa, K Nakashiro, T Sumida, S Shintani… - Head & …, 2008 - Wiley Online Library
… be useful for molecular targeting of oral cancer. Finally, the possibility of using molecular …
molecular targeted therapy and offer several examples of promising molecular targets in oral

[HTML][HTML] Molecularly-targeted therapy for the oral cancer stem cells

Y Ohnishi, H Yasui, M Nozaki, M Nakajima - Japanese Dental Science …, 2018 - Elsevier
cancers, as well as oral cancer. The mechanisms of action and toxicities of targeted therapies
differ from … Targeted therapies are generally better tolerated than traditional chemotherapy. …

Oral complications of targeted cancer therapies: a narrative literature review

AL Watters, JB Epstein, M Agulnik - Oral oncology, 2011 - Elsevier
… on the oral cavity side effects of targeted therapy. Through our review of the current literature,
it is apparent that the data collected on oral cavity side effects of targeted therapy is limited …

[HTML][HTML] Targeted therapies: a new generation of cancer treatments

DE Gerber - American family physician, 2008 - aafp.org
… with targeted cancer therapies is important. For instance, new-onset acne in a 70-year-old
woman with lung cancer could be a side effect of erlotinib (Tarceva), an oral … to oral cancer

Targeted cancer therapies: oral health care implications

E Georgakopoulou, J Stebbing, C Scully - The Journal of the American …, 2018 - Elsevier
… as cetuximab have improved oral cancer patients’ survival. … oral pain secondary to targeted
therapies, but approaches that are similar to those used in other cases of cancer-related oral

Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity

VM Patil, V Noronha, A Joshi, A Abhyankar, N Menon… - Oral Oncology, 2020 - Elsevier
… The benefit of paclitaxel-cetuximab combination in this study was higher in patients with
oral cancer primaries. The HRs in favour of the paclitaxel-cetuximab were 0.5 (95% CI 0.28–0.99…

Progress in targeted therapeutic drugs for oral squamous cell carcinoma

L Liu, J Chen, X Cai, Z Yao, J Huang - Surgical oncology, 2019 - Elsevier
… opens up a new way for the treatment of oral cancer and brings dawn to … oral squamous
cell carcinoma(OSCC)·In this paper, we discuss the research progress of targeted therapeutic

Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer

K Vyas, M Rathod, MM Patel - Nanomedicine: Nanotechnology, Biology …, 2023 - Elsevier
… , microbubble mediated ultrasonic therapy, phototherapies, and site-… targeted and nano-based
drug delivery systems in order to improve patient health and survival rates in oral cancer

[HTML][HTML] Tumor‑targeting bacterial therapy: A potential treatment for oral cancer

S Liu, X Xu, X Zeng, L Li, Q Chen… - Oncology letters, 2014 - spandidos-publications.com
… of oral cancer, one of the most common types of cancer worldwide. In this … targeted therapy
is discussed and particular bacterial strains that may have great therapeutic potential in oral

Current trends of targeted therapy for oral squamous cell carcinoma

H Li, Y Zhang, M Xu, D Yang - Journal of cancer research and clinical …, 2022 - Springer
targeted therapy. Here, the latest advances of target therapy for OSCC are reviewed, and their
therapeutic … to realize tumor site-specific drug release and targeted therapy of oral cancer. …